89 related articles for article (PubMed ID: 19243255)
1. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
Djokić D; Janković D; Nikolić N
Cancer Biother Radiopharm; 2009 Feb; 24(1):129-36. PubMed ID: 19243255
[TBL] [Abstract][Full Text] [Related]
2. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
3. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
4. Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA.
Washburn LC; Biniakiewicz DS; Maxon HR
Nucl Med Biol; 1995 Jul; 22(5):689-91. PubMed ID: 7581181
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of (99m)Tc-DMSA lyophilized kit for renal imaging.
Jan SU; Abbass HG
Pak J Pharm Sci; 2013 May; 26(3):547-51. PubMed ID: 23625428
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
7. Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex.
Djokić DDj; Janković DLj; Nikolić NS
Bioorg Med Chem; 2008 Apr; 16(8):4457-65. PubMed ID: 18331797
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of 188Re(V)-meso-DMSA and 188Re(V)-rac-DMSA: preparation and in vivo evaluation in nude mice xenografted with a neuroendocrine tumor.
Park JY; Lee TS; Choi TH; Cheon GJ; Choi CW; Awh OD
Nucl Med Biol; 2007 Nov; 34(8):1029-36. PubMed ID: 17998108
[TBL] [Abstract][Full Text] [Related]
9. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
Babbar A; Kashyap R; Chauhan UP
J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
[TBL] [Abstract][Full Text] [Related]
10. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeled L-lysine for tumor imaging.
Karacalioglu AO; Yang DJ; Azhdarinia A; Mendez R; Oh C; Kohanim S; Chanda M; Greenwell AC; Yu DF; Kim EE
Acad Radiol; 2006 Nov; 13(11):1327-37. PubMed ID: 17070450
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
Chauhan UP; Babbar A; Kashyap R; Prakash R
Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
[TBL] [Abstract][Full Text] [Related]
13. Stability of the radiopharmaceutical [99mTc]DMSA: study of the ligand exchange reaction with [99Tc]EDTA.
Garcia Muñoz M; Garcia Domenech R; Galvez Alvarez J; Moreno Frigols J
Int J Appl Radiat Isot; 1983 Nov; 34(11):1505-8. PubMed ID: 6315599
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two 99mTc(V)-dimercaptosuccinic acid preparations.
Jeghers O; Puttemans N; Urbain D; Lefebvre J; Ham HR
Int J Rad Appl Instrum A; 1987; 38(1):13-8. PubMed ID: 3030963
[TBL] [Abstract][Full Text] [Related]
15. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
[TBL] [Abstract][Full Text] [Related]
16. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid.
Blower PJ; Singh J; Clarke SE
J Nucl Med; 1991 May; 32(5):845-9. PubMed ID: 1850782
[TBL] [Abstract][Full Text] [Related]
17. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
Yen TC; King KL; Yang AH; Liu RS; Yeh SH
J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
[TBL] [Abstract][Full Text] [Related]
18. Preparation and biological characterization of isomeric 188Re(V) oxocomplexes with tetradentate S4 ligands derived from meso-dimercaptosuccinic acid for labeling of biomolecules.
Seifert S; Heinrich T; Jentschel C; Smuda C; Bergmann R; Pietzsch HJ
Bioconjug Chem; 2006; 17(6):1601-6. PubMed ID: 17105241
[TBL] [Abstract][Full Text] [Related]
19. Simple and reliable preparation of pentavalent 99Tcm-dimercaptosuccinic acid at alkaline pH without oxygen bubbling.
Oh SJ; Ha HJ; Moon DH; Ryu JS; Lee HK
Nucl Med Commun; 2001 Jun; 22(6):613-6. PubMed ID: 11403170
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rac- and meso-2,3-dimercaptosuccinic acids for chelation of mercury and cadmium using chemical speciation models.
Fang X; Hua F; Fernando Q
Chem Res Toxicol; 1996; 9(1):284-90. PubMed ID: 8924605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
